| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $292.0M | — | +26.5% |
| Cost of Revenue | $78.9M | — | +18.3% |
| Gross Profit | $213.1M | — | +29.9% |
| R&D Expense | $83.0M | — | +17.9% |
| SG&A Expense | $46.3M | — | +6.7% |
| Operating Income | $44.5M | — | +88.7% |
| Pre-tax Income | $55.6M | — | +58.7% |
| Income Tax | $12.1M | — | +9773.6% |
| Net Income | $43.5M | — | +23.7% |
| EPS (Basic) | $0.93 | — | +19.2% |
| EPS (Diluted) | $0.89 | — | +23.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.14B | +9.9% | +28.8% |
| Accounts Receivable | $125.1M | -23.2% | +9.5% |
| Current Assets | $1.51B | +4.8% | +23.5% |
| Total Assets | $2.06B | +3.3% | +46.7% |
| Current Liabilities | $574.1M | +4.2% | +26.3% |
| Total Liabilities | $666.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $150.8M | — | +42.7% |
| Capital Expenditures | $132K | — | -89.9% |
| Investing Cash Flow | -$16.7M | — | -58.8% |
| Financing Cash Flow | -$31.9M | — | -1119.9% |
| Free Cash Flow | $150.6M | — | +44.4% |
| +30.8% |
| Stockholders' Equity | $1.39B | +3.3% | +55.7% |